Literature DB >> 6624870

Does reduction of intraocular pressure (IOP) prevent visual field loss in glaucoma?

D M Cockburn.   

Abstract

The visual fields of 54 eyes (27 patients) having a medical diagnosis of open-angle glaucoma and receiving treatment were compared with the visual fields recorded at the time of diagnosis of the disease. Visual fields remained stable in 34 (62%) of the glaucomatous eyes. However, reduction of the intraocular pressure (IOP) did not prevent the progression of existing field defects in 16 of 21 eyes nor prevent field damage from occurring in 4 of 33 eyes which had normal visual fields at the commencement of treatment. The presence of a visual field defect at the time of diagnosis was clearly associated with a high risk of continued field decay during treatment. Intraocular pressure at the time of diagnosis did not identify which eyes would develop visual field loss or suffer further loss despite hypotensive treatment. Likewise, the extent to which the IOP was reduced by treatment did not appear to be related to the decay of visual field.

Entities:  

Mesh:

Year:  1983        PMID: 6624870     DOI: 10.1097/00006324-198308000-00009

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  8 in total

Review 1.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2017-01-25

Review 2.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kanchan Ramchand; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

3.  Association of serum retinol concentration with normal-tension glaucoma.

Authors:  Ruiqi Pang; Shuo Feng; Kai Cao; Yunxiao Sun; Yiqin Guo; Dandan Ma; Chi Pui Pang; Xiangyi Liu; Jingyu Qian; Yuan Xie; Yan Shi; Hailong He; Jun Peng; Congyan Chen; Jing Cui; Siloka A Labisi; Yue Zhang; Yingdi Fu; Jiaying Li; Yue Wan; Chen Xin; Hanruo Liu; Qing Zhang; Robert N Weinreb; Huaizhou Wang; Ningli Wang
Journal:  Eye (Lond)       Date:  2021-08-12       Impact factor: 4.456

4.  MIND diet lowers risk of open-angle glaucoma: the Rotterdam Study.

Authors:  Joëlle E Vergroesen; Tosca O E de Crom; Cornelia M van Duijn; Trudy Voortman; Caroline C W Klaver; Wishal D Ramdas
Journal:  Eur J Nutr       Date:  2022-09-20       Impact factor: 4.865

Review 5.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Crystallins Play a Crucial Role in Glaucoma and Promote Neuronal Cell Survival in an In Vitro Model Through Modulating Müller Cell Secretion.

Authors:  Hanhan Liu; Katharina Bell; Anja Herrmann; Stefan Arnhold; Karl Mercieca; Fabian Anders; Kerstin Nagel-Wolfrum; Solon Thanos; Verena Prokosch
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

7.  Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.

Authors:  Alena Z Minton; Nitasha R Phatak; Dorota L Stankowska; Shaoqing He; Hai-Ying Ma; Brett H Mueller; Ming Jiang; Robert Luedtke; Shaohua Yang; Colby Brownlee; Raghu R Krishnamoorthy
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

8.  Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.

Authors:  Verena Prokosch; Maurice Schallenberg; Solon Thanos
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.